Neuroprotective Effect of Duloxetine on Chronic Cerebral Hypoperfusion-Induced Hippocampal Neuronal Damage

다국어 초록 (Multilingual Abstract)

Chronic cerebral hypoperfusion (CCH), which is associated with onset of vascular dementia, causes cognitive impairment and neuropathological alterations in the brain. In the present study, we examined the neuroprotective effect of duloxetine (DXT), a potent and balanced serotonin/norepinephrine reuptake inhibitor, on CCH-induced neuronal damage in the hippocampal CA1 region using a rat model of permanent bilateral common carotid arteries occlusion. We found that treatment with 20 mg/kg DXT could attenuate the neuronal damage, the reduction of phosphorylations of mTOR and p70S6K as well as the elevations of TNF-α and IL- 1β levels in the hippocampal CA1 region at 28 days following CCH. These results indicate that DXT displays the neuroprotective effect against CCH-induced hippocampal neuronal death, and that neuroprotective effect of DXT may be closely related with the attenuations of CCH-induced decrease of mTOR/p70S6K signaling pathway as well as CCH-induced neuroinflammatory process.

참고문헌 (Reference)

1 Laplante, M., "mTOR signaling in growth control and disease" 149 : 274-293, 2012

2 Pullen, N., "The modular phosphorylation and activation of p70s6k" 410 : 78-82, 1997

3 Choi, H. S., "The anti-inflammatory activity of duloxetine, a serotonin/norepinephrine reuptake inhibitor, prevents kainic acid-induced hippocampal neuronal death in mice" 358 : 390-397, 2015

4 박진아, "Temporal changes in mammalian target of rapamycin (mTOR) and phosphorylated-mTOR expressions in the hippocampal CA1 region of rat with vascular dementia" 대한수의학회 18 (18): 11-16, 2017

5 Singh, P., "Selective serotonin-norepinephrine re-uptake inhibition limits renovas-cular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury" 13 : 135-146, 2016

6 Qu, J., "Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion" 171 : 3702-3715, 2014

7 Dufner, A., "Ribosomal S6 kinase signaling and the control of translation" 253 : 100-109, 1999

8 Plassman, B. L., "Prevalence of dementia in the United States: the aging, demographics, and memory study" 29 : 125-132, 2007

9 Lee, T. K., "Pretreated duloxetine protects hippocampal CA1 pyramidal neurons from ischemia-reperfusion injury through decreases of glial activation and oxidative stress" 370 : 229-236, 2016

10 Farkas, E., "Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases" 54 : 162-180, 2007

11 Shi, G. D., "PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway" 404 : 941-945, 2011

12 Koh, P. O., "Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway" 444 : 74-78, 2008

13 Jia, Y., "Lipoxin A4 methyl ester alleviates vascular cognition impairment by regulating the expression of proteins related to autophagy and ER stress in the rat hippocampus" 20 : 475-487, 2015

14 Ueno, Y., "L-carnitine enhances axonal plasticity and improves white-matter lesions after chronic hypoperfusion in rat brain" 35 : 382-391, 2015

15 Yang, H., "Functional protection of learning and memory abilities in rats with vascular dementia" 32 : 689-700, 2014

16 Koh, P. O., "Ferulic acid attenuates focal cerebral ischemia-induced decreases in p70S6 kinase and S6 phosphorylation" 555 : 7-11, 2013

17 Farkas, E., "Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain" 108 : 57-64, 2004

18 Koh, P. O., "Estradiol attenuates the focal cerebral ischemic injury through mTOR/p70S6 kinase signaling pathway" 436 : 62-66, 2008

19 Lee, C. H., "Effects of melatonin on cognitive impairment and hippocampal neuronal damage in a rat model of chronic cerebral hypoperfusion" 11 : 2240-2246, 2016

20 Goldstein, D. J., "Duloxetine vs. placebo in patients with painful diabetic neuropathy" 116 : 109-118, 2005

21 Nemeroff, C. B., "Duloxetine for the treatment of major depressive disorder" 36 : 106-132, 2002

22 Guay, D. R., "Duloxetine for management of stress urinary incontinence" 3 : 25-38, 2005

23 Gingras, A. C., "Control of translation by the target of rapamycin proteins" 27 : 143-174, 2001

24 He, X. L., "Chrysin improves cognitive deficits and brain damage induced by chronic cerebral hypoperfusion in rats" 680 : 41-48, 2012

25 Cechetti, F., "Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment" 87 : 109-116, 2012

26 Janelidze, S., "Alterations of Akt1 ($PKB{\alpha}$) and $p70^{S6K}$ in transient focal ischemia" 8 : 147-154, 2001